Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Insomnia Disorder
Author Information
Author(s): Zhang Shuai MD PhD, Zhao Yanan MD PhD, Qin Zongshi MD PhD, Han Ying MD, He Jiakai MD PhD, Zhao Bin MD, Wang Lei MD PhD, Duan Yuting PhD, Huo Jin MD, Wang Tuoran MM, Wang Yu MD PhD, Rong Peijing MD PhD
Primary Institution: Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
Hypothesis
taVNS would show greater improvement in sleep severity after 8 weeks of treatment.
Conclusion
taVNS significantly reduced insomnia severity and improved sleep quality compared to sham stimulation.
Supporting Evidence
- taVNS achieved clinically significant improvements in PSQI scores compared to sham stimulation.
- 68 participants completed the 8-week intervention.
- taVNS showed a clinically meaningful 4.2-point greater reduction in PSQI compared to sham.
- Secondary outcomes also showed favorable results for taVNS.
- taVNS was associated with sustained benefits lasting for 20 weeks.
Takeaway
This study tested a new treatment for people who can't sleep well, and it found that this treatment helped them sleep better.
Methodology
Randomized clinical trial comparing taVNS and sham taVNS over 8 weeks with follow-up assessments.
Potential Biases
None reported.
Limitations
The study used maximum tolerable stimulation intensity and was affected by COVID-19, which may have influenced participant recruitment.
Participant Demographics
Mean age 45.2 years, 75% female in taVNS group; 44.6 years, 86.1% female in sham group.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI, −9.3 to −7.0 for taVNS group; −5.1 to −2.7 for sham group.
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website